 But I think we are at a point in time where we do see that there are some new treatments that are coming into the marketplace. FDA has approved two substances, two drugs, that have been shown to slow down the rate at which the disease progresses. There is a new pharmacological treatment that a panel has recommended to FDA that they approve it, and it's very likely that they are going to approve it.